期刊
EUROPEAN UROLOGY ONCOLOGY
卷 5, 期 2, 页码 164-175出版社
ELSEVIER
DOI: 10.1016/j.euo.2021.10.001
关键词
Bone metastasis; Fibroblast growth factor; receptor 1; Ladinin 1; Prostate cancer
资金
- Prostate Cancer Foundation
- National Center Institute (NCI) Cancer Center Support Grant [P30CA16672]
- Cancer Center Prostate Cancer SPORE (National Institutes of Health) [[NIH]/NCI P50 CA140388-08]
- DOD-PCRP [W81XWH-14-1-0554]
- Janssen Pharmaceutical Companies of Johnson Johnson
- David H. Koch Center for Applied Research in Genitourinary Cancers at MD Anderson, Houston, TX
- NIH/NCI [5U24CA199461, 5P30CA016672, 2P50CA140388-06A1]
This study found that FGFR1 expression plays an important role in bone metastasis of prostate cancer, and its activity enhanced bone metastasis and survival rate in mice, and the human samples also showed that FGFR1 were enriched in bone metastasis of castration-resistant prostate cancer. In addition, the study also found that the LAD1 protein co-expressed with FGFR1 plays an important role in the bone metastasis of prostate cancer.
Background: No curative therapy is currently available for metastatic prostate cancer (PCa). The diverse mechanisms of progression include fibroblast growth factor (FGF) axis activation. Objective: To investigate the molecular and clinical implications of fibroblast growth factor receptor 1 (FGFR1) and its isoforms (alpha/beta) in the pathogenesis of PCa bone metastases. Design, setting, and participants: In silico, in vitro, and in vivo preclinical approaches were used. RNA-sequencing and immunohistochemical (IHC) studies in human samples were conducted. Outcome measurements and statistical analysis: In mice, bone metastases (chi-square/Fisher's test) and survival (Mantel-Cox) were assessed. In human samples, FGFR1 and ladinin 1 (LAD1) analysis associated with PCa progression were evaluated (IHC studies, Fisher's test). Results and limitations: FGFR1 isoform expression varied among PCa subtypes. Intracardiac injection of mice with FGFR1-expressing PC3 cells reduced mouse survival (alpha, p < 0.0001; b, p = 0.032) and increased the incidence of bone metastases (alpha, p < 0.0001; beta, p = 0.02). Accordingly, IHC studies of human castration-resistant PCa (CRPC) bone metastases revealed significant enrichment of FGFR1 expression compared with treatment-naive, nonmetastatic primary tumors (p = 0.0007). Expression of anchoring filament protein LAD1 increased in FGFR1-expressing PC3 cells and was enriched in human CRPC bone metastases (p = 0.005). Conclusions: FGFR1 expression induces bone metastases experimentally and is significantly enriched in human CRPC bone metastases, supporting its prometastatic effect in PCa. LAD1 expression, found in the prometastatic PCa cells expressing FGFR1, was also
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据